R01 CA187918/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2015	4
2016	6
2017	9
2018	11
2019	7
2020	6
2021	2
2022	2
2023	1
2024	0

1

CDK4/6 inhibition triggers anti-tumour immunity.

Goel S, DeCristo MJ, Watt AC, BrinJones H, Sceneay J, Li BB, Khan N, Ubellacker JM, Xie S, Metzger-Filho O, Hoog J, Ellis MJ, Ma CX, Ramm S, Krop IE, Winer EP, Roberts TM, Kim HJ, McAllister SS, Zhao JJ. Goel S, et al. Nature. 2017 Aug 24;548(7668):471-475. doi: 10.1038/nature23465. Epub 2017 Aug 16. Nature. 2017. PMID: 28813415 Free PMC article.

2

CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest.

Goel S, DeCristo MJ, McAllister SS, Zhao JJ. Goel S, et al. Trends Cell Biol. 2018 Nov;28(11):911-925. doi: 10.1016/j.tcb.2018.07.002. Epub 2018 Jul 27. Trends Cell Biol. 2018. PMID: 30061045 Free PMC article. Review.

3

Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Butler LM, Perone Y, Dehairs J, Lupien LE, de Laat V, Talebi A, Loda M, Kinlaw WB, Swinnen JV. Butler LM, et al. Adv Drug Deliv Rev. 2020;159:245-293. doi: 10.1016/j.addr.2020.07.013. Epub 2020 Jul 23. Adv Drug Deliv Rev. 2020. PMID: 32711004 Free PMC article. Review.

4

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.

Ding L, Kim HJ, Wang Q, Kearns M, Jiang T, Ohlson CE, Li BB, Xie S, Liu JF, Stover EH, Howitt BE, Bronson RT, Lazo S, Roberts TM, Freeman GJ, Konstantinopoulos PA, Matulonis UA, Zhao JJ. Ding L, et al. Cell Rep. 2018 Dec 11;25(11):2972-2980.e5. doi: 10.1016/j.celrep.2018.11.054. Cell Rep. 2018. PMID: 30540933 Free PMC article.

5

Epigenetic regulation of RTK signaling.

Spangle JM, Roberts TM. Spangle JM, et al. J Mol Med (Berl). 2017 Aug;95(8):791-798. doi: 10.1007/s00109-017-1546-0. Epub 2017 Jun 6. J Mol Med (Berl). 2017. PMID: 28589435 Free PMC article. Review.

6

Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.

Zadra G, Loda M. Zadra G, et al. Cold Spring Harb Perspect Med. 2018 Oct 1;8(10):a030569. doi: 10.1101/cshperspect.a030569. Cold Spring Harb Perspect Med. 2018. PMID: 29229664 Free PMC article. Review.

7

O-GlcNAc Transferase - An Auxiliary Factor or a Full-blown Oncogene?

Itkonen HM, Loda M, Mills IG. Itkonen HM, et al. Mol Cancer Res. 2021 Apr;19(4):555-564. doi: 10.1158/1541-7786.MCR-20-0926. Epub 2021 Jan 20. Mol Cancer Res. 2021. PMID: 33472950 Review.

8

Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies.

Zadra G, Batista JL, Loda M. Zadra G, et al. Mol Cancer Res. 2015 Jul;13(7):1059-72. doi: 10.1158/1541-7786.MCR-15-0068. Epub 2015 May 8. Mol Cancer Res. 2015. PMID: 25956158 Free PMC article. Review.

9

The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer.

Spangle JM, Roberts TM, Zhao JJ. Spangle JM, et al. Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):123-131. doi: 10.1016/j.bbcan.2017.03.002. Epub 2017 Mar 14. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28315368 Free PMC article. Review.

10

Targeted Profiling of RNA Translation.

Li BB, Qian C, Roberts TM, Zhao JJ. Li BB, et al. Curr Protoc Mol Biol. 2019 Jan;125(1):e71. doi: 10.1002/cpmb.71. Epub 2018 Oct 22. Curr Protoc Mol Biol. 2019. PMID: 30346115 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year